Ignite Creation Date:
2024-05-06 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05272371
Status:
RECRUITING
Last Update Posted:
2022-03-09
First Post:
2022-03-01
Brief Title:
Immunotherapy With Dinutuximab Beta in Combination With Chemotherapy for the Treatment of Patients With Primary Neuroblastoma Refractory to Standard Therapy and With Relapsed or Progressive Disease
Sponsor:
Jagiellonian University
Organization:
Jagiellonian University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-03-01
First Submit QC Date:
March 8 2022
Study First Post Date:
2022-03-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-08
Last Update Post Date:
2022-03-09
Last Update Post Date Type:
ACTUAL